Literature DB >> 20863736

Role for interferon regulatory factors in autoimmunity.

Christophe Richez1, Thomas Barnetche, Corinne Miceli-Richard, Patrick Blanco, Jean-François Moreau, Ian Rifkin, Thierry Schaeverbeke.   

Abstract

Interferon regulatory factors (IRFs) were first identified during studies of type I interferons. Since then, many investigations have established that IRFs are involved in regulating the innate immune response, the development of various immune cell types, and carcinogenesis. Several genetic studies have identified genetic variants, most notably IRF5, associated with an increased risk of autoimmune disease. The biological role for IRFs in autoimmune diseases has been evaluated not only in vitro, but also in vivo in various murine models. Here, we discuss the role for the various IRFs, particularly in toll-like receptor signaling pathways. We also review the evidence supporting a role for IRFs in dysimmune diseases.
Copyright © 2010 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863736     DOI: 10.1016/j.jbspin.2010.08.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

1.  IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.

Authors:  Leah Cushing; Aaron Winkler; Scott A Jelinsky; Katherine Lee; Wouter Korver; Rachael Hawtin; Vikram R Rao; Margaret Fleming; Lih-Ling Lin
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

Review 2.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

3.  Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding.

Authors:  Pablo De Ioannes; Carlos R Escalante; Aneel K Aggarwal
Journal:  Nucleic Acids Res       Date:  2011-05-19       Impact factor: 16.971

4.  Activation of interferon regulatory factor 5 by site specific phosphorylation.

Authors:  Hui-Chen Chang Foreman; Sarah Van Scoy; Tsu-Fan Cheng; Nancy C Reich
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

5.  Therapeutic effects of acupuncture with MOK, a polyherbal medicine, on PTU-induced hypothyroidism in rats.

Authors:  Ji Hye Hwang; Hyo Won Jung; Seok Yong Kang; An Na Kang; Jun Nan Ma; Xiang Long Meng; Min Sub Hwang; Yong-Ki Park
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

6.  The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India.

Authors:  Panneer Devaraju; Sonal Mehra; Reena Gulati; Paul T Antony; Vikramraj K Jain; Durga Prasanna Misra; Vir Singh Negi
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

7.  IFI44L expression is regulated by IRF-1 and HIV-1.

Authors:  Yutong Li; Junshi Zhang; Chenchen Wang; Wentao Qiao; Yue Li; Juan Tan
Journal:  FEBS Open Bio       Date:  2020-11-27       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.